{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:07:38Z","timestamp":1770505658489,"version":"3.49.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.semarthrit.2003.11.003","type":"journal-article","created":{"date-parts":[[2004,8,11]],"date-time":"2004-08-11T14:34:09Z","timestamp":1092234849000},"page":"442-453","source":"Crossref","is-referenced-by-count":23,"title":["Endothelin and pulmonary arterial hypertension"],"prefix":"10.1016","volume":"34","author":[{"given":"Yolanda","family":"Braun-Moscovici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Menahem","family":"Nahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Balbir-Gurman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2003.11.003_BIB1","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1073\/pnas.86.8.2863","article-title":"The human endothelin family","volume":"86","author":"Inoue","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1592\/phco.22.1.54.33505","article-title":"Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents","volume":"22","author":"Ergul","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/00004872-199816080-00001","article-title":"Endothelin as a regulator of cardiovascular function in health and disease","volume":"16","author":"Haynes","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB5","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0021-9258(18)41966-7","article-title":"Polar secretion of endothelin-1 by cultured endothelial cells","volume":"267","author":"Wagner","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1994.1462","article-title":"Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch","volume":"200","author":"McArthur","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/ajpcell.1992.263.2.C389","article-title":"Physiological fluid shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium","volume":"C263","author":"Malek","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1172\/JCI854","article-title":"Reduced extracellular pH increases endothelin-1 secretion by human renal micro-vascular endothelial cells","volume":"101","author":"Wesson","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB9","first-page":"2105","article-title":"Prolonged exercise causes an increase in endothelin-1 production in the heart in rats","volume":"H275","author":"Maeda","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0006-291X(90)91989-6","article-title":"Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia","volume":"169","author":"Rakugi","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.RES.70.6.1191","article-title":"Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium","volume":"70","author":"Boulanger","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0026-0495(91)90168-V","article-title":"Effects of glucose and insulin on immunoreactive endothelin-1 release from cultured bovine endothelial cells","volume":"40","author":"Hattori","year":"1991","journal-title":"Metabolism"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB13","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/01.RES.68.6.1768","article-title":"Hirudin and nitrates inhibit the thrombin-induced release of endothelin from the intact porcine aorta","volume":"68","author":"Boulanger","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.HYP.19.6.753","article-title":"Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells","volume":"19","author":"Imai","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.32.1.89","article-title":"Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression","volume":"32","author":"Matsuura","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB16","first-page":"902","article-title":"Endothelin-1 is induced by cytokines in human vascular smooth muscle cells","volume":"55","author":"Woods","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB17","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1097\/00005344-200036051-00119","article-title":"Signal transduction pathways in cytokine stimulation endothelin-1 release from human vascular smooth muscle cells","volume":"36","author":"Woods","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB18","first-page":"H944","article-title":"Role of cyclic nucleotides in the regulation of endothelin-1 production by human endothelial cells","volume":"266","author":"Stewart","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB19","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI118092","article-title":"Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression","volume":"96","author":"Fujisaki","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB20","first-page":"325","article-title":"Endothelins","volume":"46","author":"Rubanyi","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1098-1128(199701)17:1<17::AID-MED2>3.0.CO;2-W","article-title":"Inhibitors of endothelin","volume":"17","author":"Webb","year":"1997","journal-title":"Med Res Rev"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/01.CIR.82.1.188","article-title":"Threshold concentrations of endothelin-1 potentiates contractions to norepinephrine and serotonin in human arteries","volume":"82","author":"Yang","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB23","first-page":"H2629","article-title":"Evidence of the endothelin-1 autocrine loop in cardiac myocytes","volume":"40","author":"Thomas","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(95)91504-4","article-title":"Evidence of endothelin-1-mediated vasoconstriction in severe chronic heart failure","volume":"346","author":"Kiowski","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM199803193381202","article-title":"The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension","volume":"338","author":"Krum","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","article-title":"Increased plasma endothelin-1 in pulmonary hypertension","volume":"114","author":"Stewart","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB27","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1182\/blood.V84.8.2531.2531","article-title":"Stimulation of interleukin-6 production by endothelin in rat bone marrow-derived stromal cells","volume":"84","author":"Agui","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB28","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V92.9.3064","article-title":"Endothelin-1 induces production of the neutrophil chemotactic factor interleukin-8 by human brain-derived endothelial cells","volume":"92","author":"Hofman","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/bbrc.1997.7940","article-title":"Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells","volume":"242","author":"Peifley","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"suppl 1","key":"10.1016\/j.semarthrit.2003.11.003_BIB30","doi-asserted-by":"crossref","first-page":"S545","DOI":"10.1097\/00005344-199800001-00157","article-title":"Endothelin-1 regulation of intercellular adhesion molecule-1 expression in normal and sclerodermal fibroblasts","volume":"31","author":"Xu","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.1780340807","article-title":"Endothelin, an endothelian dependent vasoconstrictor in sclerderma","volume":"34","author":"Kahaleh","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB32","first-page":"150","article-title":"Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen","volume":"1","author":"Dubin","year":"1989","journal-title":"J Vas Biol Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1006\/bbrc.1995.2560","article-title":"Endothelin-induced collagen remodeling in experimental pulmonary hypertension","volume":"215","author":"Mansoor","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0049-3848(95)90866-E","article-title":"In vitro effect of endothelin-1 on collagen, and ADP-induced aggregation in human whole blood and platelet rich plasma","volume":"77","author":"Knofler","year":"1995","journal-title":"Thromb Res"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB37","series-title":"Executive summary from the World Symposium on Primary Pulmonaty Hypertension 1998","author":"Rich","year":"2002"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0272-5231(05)70284-7","article-title":"Risk factors for pulmonary arterial hypertension","volume":"22","author":"Humbert","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780290409","article-title":"Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis","volume":"29","author":"Stupi","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002960050074","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"18","author":"Shen","year":"1999","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB42","first-page":"282","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"29","author":"Tanaka","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1191\/096120300678828361","article-title":"Primary and secondary pulmonary hypertension in systemic lupus erythematosus","volume":"9","author":"Pan","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200108023450502","article-title":"Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred","volume":"345","author":"Newman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jmg.37.10.741","article-title":"Sporadic primary pulmonary hypertension is associated with germ-line mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family","volume":"37","author":"Thomson","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB46","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1164\/rccm.200110-028PP","article-title":"New treatment for pulmonary hypertension","volume":"165","author":"Hoeper","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB47","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB48","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0002-8703(98)70276-5","article-title":"Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension","volume":"135","author":"Dupuis","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.1996.tb32580.x","article-title":"Vascular endothelial growth factor in pulmonary hypertension","volume":"796","author":"Voelkel","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/ajrccm.165.4.2012112","article-title":"Chemokine RANTES in severe pulmonary hypertension","volume":"165","author":"Dorfmuller","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.70.4.657","article-title":"Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation","volume":"70","author":"Yock","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB52","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.CIR.84.3.1145","article-title":"Adenosine as a vasodilator in primary pulmonary hypertension","volume":"84","author":"Morgan","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/thx.52.4.369","article-title":"Nitric oxide and prostacyclin as test agents of vasoreactivity in severe precapillary pulmonary hypertension","volume":"52","author":"Jolliet","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB54","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/35.10.989","article-title":"Pulmonary hypertension in systemic sclerosis","volume":"35","author":"Koh","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1378\/chest.89.4.497","article-title":"Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension","volume":"89","author":"Barst","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension","volume":"70","author":"Fuster","year":"1984","journal-title":"Cirulation"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB58","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB59","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB61","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0272-5231(05)70289-6","article-title":"Medical therapy of pulmonary hypertension","volume":"22","author":"Galie","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB62","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Treprostinil Study Group. Continuous subcutaneous infusions of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB63","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0735-1097(99)00312-5","article-title":"Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension","volume":"34","author":"Nagaya","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB64","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-124-9-199605010-00006","article-title":"Aerosolized prostacyclin and iloprost in severe pulmonary hypertension","volume":"124","author":"Olschewski","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB65","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB66","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJM200006223422503","article-title":"Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue","volume":"342","author":"Hoeper","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB67","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effect of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension","volume":"39","author":"Galie","year":"2002","journal-title":"J Am Coll Card"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB68","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM200011023431814","article-title":"Sildenafil in primary pulmonary hypertension","volume":"343","author":"Prasad","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB69","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/hc3601.096826","article-title":"Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension","volume":"104","author":"Wilkens","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB70","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","article-title":"Combined treatment with oral sildenafil and inhaled iloprost for severe pulmonary hypertension","volume":"136","author":"Ghofrani","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB71","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1164\/ajrccm.163.4.2007116","article-title":"Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension","volume":"163","author":"Nagaya","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB72","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.CIR.102.4.411","article-title":"Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension","volume":"102","author":"Williamson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB73","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/BF00053029","article-title":"Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans","volume":"10","author":"Sutsch","year":"1996","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB74","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1011408425878","article-title":"Clinical experience with endothelin receptor antagonists in chronic heart failure","volume":"6","author":"Seed","year":"2001","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB75","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.CIR.103.7.973","article-title":"Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III and IV congestive heart failure","volume":"103","author":"Torre-Amione","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB76","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0735-1097(00)00649-5","article-title":"Acute hemodynamic and neurohumoral effects of selective ET (A) receptor blockade in patients with congestive heart failure","volume":"35","author":"Spieker","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB77","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1476-5381.1995.tb15868.x","article-title":"Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung","volume":"115","author":"Filep","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB78","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm.156.2.9607123","article-title":"Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of endothelin receptor antagonist","volume":"156","author":"Park","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB79","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1152\/jappl.1995.79.6.2122","article-title":"Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats","volume":"79","author":"Chen","year":"1995","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB80","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB81","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.161.2.9906015","article-title":"Clinical correlates and prognostic significance of 6-minute walk test in patients with primary pulmonary hypertension","volume":"161","author":"Miyamoto","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB82","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1378\/chest.124.1.247","article-title":"Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension. A 1-year follow-up study","volume":"124","author":"Sitbon","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB83","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.semarthrit.2003.11.003_BIB84","first-page":"109","article-title":"Effects of the oral endothelial receptor antagonist bosentan in a sub-group of patients with pulmonary artery hypertension related to scleroderma (abstr.)","volume":"61","author":"Black","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB85","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00005-5","article-title":"Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary artery hypertension","volume":"73","author":"Barst","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB86","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000056104.49686.4B","article-title":"Influence of inhaled iloprost on transpulmonary gradient of big endothelin in patients with pulmonary hypertension","volume":"107","author":"Wilkens","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB87","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1183\/09031936.03.00008003","article-title":"Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids","volume":"22","author":"Hoeper","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB88","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1345\/aph.1C256","article-title":"Bosentan for the treatment of pulmonary arterial hypertension","volume":"37","author":"Kanyon","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB89","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/pupt.2000.0237","article-title":"Attenuation of pulmonary vascular hypertension and cardiac hyperthrophy with sitaxsentan sodium, an orally active ET (A) receptor antagonist","volume":"13","author":"Tilton","year":"2000","journal-title":"Pulmonary Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2003.11.003_BIB90","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1378\/chest.121.6.1860","article-title":"Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension","volume":"121","author":"Barst","year":"2002","journal-title":"Chest"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017204001520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017204001520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T23:19:41Z","timestamp":1624576781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017204001520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0049017204001520"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2003.11.003","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}